Careers  |  Sign In  |  Register  |   Twitter

Latest in Rheumatology

Reuters Health • The Doctor's Channel Daily Newscast

Abatacept does not increase malignancies in rheumatoid arthritis patients

NEW YORK (Reuters Health) – Abatacept, an agent that modifies the costimulatory signal required for T-cell activation, does not increase malignancy rates in patients with rheumatoid arthritis (RA), according to researchers reporting on clinical trial safety data. Abatacept is effective in RA, but its...

Reuters Health • The Doctor's Channel Daily Newscast

High-dose vitamin D safe for metastatic breast cancer, but benefits questionable

NEW YORK (Reuters Health) – New research suggests that high-dose vitamin D can be safely given to breast cancer patients with bone metastases, but it will not affect palliation or bone resorption. The potential of vitamin D for breast cancer treatment and prevention “has gained considerable...

Reuters Health • The Doctor's Channel Daily Newscast

Adverse events common with low- to medium-dose glucocorticoids

NEW YORK (Reuters Health) - In patients receiving glucocorticoids for inflammatory diseases, adverse events are very common, even at low to medium doses, according to a meta-analysis by researchers in the Netherlands. In fact, they report in the December Annals of the Rheumatic Diseases, the overall...